Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer.

Medchemcomm

State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute For Applied Research in Medicine and Health , Macau University of Science and Technology, Macau SAR , China . Email: ; Email: ; Email: ; ; Tel: +853 8897 2409.

Published: October 2017

ALK-fusion proteins play a fundamental role in the development of about 5% of non-small cell lung cancers. Herein, we identified the compound 5067-0952 as a potent ALK inhibitor, which inhibited cell growth, induced apoptosis, and suppressed the phosphorylation of ALK, subsequently blocking its downstream signaling pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071718PMC
http://dx.doi.org/10.1039/c7md00305fDOI Listing

Publication Analysis

Top Keywords

non-small cell
8
cell lung
8
identification potent
4
potent kinase
4
kinase inhibitor
4
inhibitor targeting
4
targeting eml4-alk
4
eml4-alk fusion
4
fusion protein
4
protein non-small
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!